4.7 Article

Dorsal root ganglia in vivo morphometry and perfusion in female patients with Fabry disease

期刊

JOURNAL OF NEUROLOGY
卷 265, 期 11, 页码 2723-2729

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s00415-018-9053-y

关键词

Magnetic resonance neurography; Dorsal root ganglia; Neuropathic pain; Peripheral neuropathy; Fabry disease

资金

  1. Medical Faculty of the University of Heidelberg
  2. Shire
  3. Sanofi Genzyme
  4. Amicus
  5. German Research Council [SFB 1158, SFB 1118]
  6. Alnylam Pharmaceuticals
  7. Marta and Erik Karberg Foundation for Medical Research

向作者/读者索取更多资源

Purpose: To examine dorsal root ganglia and the proximal nerve segments in female patients with Fabry disease by functional and morphometric magnetic resonance neurography. Methods: In this prospective multicenter study the lumbosacral dorsal root ganglia and proximal sciatic nerve were examined in ten female patients with Fabry disease by a standardized magnetic resonance neurography protocol at 3T. Volumes of dorsal root ganglia L3-S2, permeability of dorsal root ganglia L5 and S1 and the spinal nerve L5 as well as the cross-sectional area of the proximal sciatic nerve were compared to 16 gender-matched healthy controls. Results: Dorsal root ganglia were symmetrically enlarged by 54% (L3), 79% (L4), 60% (L5), 94% (S1), and 106% (S2) (p < 0.001). Additionally, permeability of the blood-tissue interface was decreased by 47% (p < 0.001). This finding was most pronounced in the peripheral zone of the dorsal root ganglia, where the cell bodies of the primary sensory neurons are located (p < 0.001). While spinal nerve permeability showed no differences compared to healthy controls, proximal sciatic nerve cross-sectional area was mildly increased by 6% (p < 0.01). Conclusion: Although heterozygous, Fabry females show severe enlarged dorsal root ganglia with a concomitant dysfunctional perfusion, even in patients with minor disease progression and in patients who are not considered for enzyme replacement therapy yet. Alterations in dorsal root ganglia volume and perfusion might serve as a very early in vivo marker for involvement of the peripheral nervous system in Fabry disease, even in patients with residual enzyme activity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据